Text-only version of this email
LIXTE Biotechnology Holdings, Inc.
The following documents have been filed with the SEC:
SEC FILING ALERT
S-3/A: Registration statement for specified transactions by certain issuers
HTML PDF
If you have any questions, or would like to contact Investor Relations, please reply to this email.
LIXTE Biotechnology Holdings, Inc.
680 E Colorado Blvd., Suite 180, Pasadena, CA 91101 United States of America
To change your subscription preferences, please click here.
Show all